S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

EPI

Essa Pharma (EPI)

Essa Pharma Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:EPI

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
02/25/2021	5:33PM	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
01/13/2021	6:00AM	PR Newswire (Canada)	ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...	TSXV:EPI	Essa Pharma Inc
12/15/2020	4:01PM	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...	TSXV:EPI	Essa Pharma Inc
11/25/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference	TSXV:EPI	Essa Pharma Inc
10/26/2020	4:01PM	PR Newswire (Canada)	ESSA Pharma Inc. Announces Delisting from the TSX-V	TSXV:EPI	Essa Pharma Inc
10/24/2020	6:18PM	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium	TSXV:EPI	Essa Pharma Inc
10/19/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc
09/21/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit	TSXV:EPI	Essa Pharma Inc
09/17/2020	4:05PM	PR Newswire (Canada)	ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020	TSXV:EPI	Essa Pharma Inc
09/14/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...	TSXV:EPI	Essa Pharma Inc
09/10/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma to Participate in Multiple Upcoming Investor Conferences	TSXV:EPI	Essa Pharma Inc
08/06/2020	7:00PM	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020	TSXV:EPI	Essa Pharma Inc
07/31/2020	9:16AM	PR Newswire (Canada)	ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000	TSXV:EPI	Essa Pharma Inc
07/29/2020	8:07AM	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - EPI	TSXV:EPI	Essa Pharma Inc
07/29/2020	8:05AM	PR Newswire (Canada)	IIROC Trading Resumption - EPI	TSXV:EPI	Essa Pharma Inc
07/28/2020	8:18PM	PR Newswire (Canada)	ESSA Pharma Announces Pricing of Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
07/28/2020	3:03PM	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - EPI	TSXV:EPI	Essa Pharma Inc
07/28/2020	3:01PM	PR Newswire (Canada)	ESSA Pharma Announces Proposed Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
07/28/2020	3:01PM	PR Newswire (Canada)	IIROC Trading Halt - EPI	TSXV:EPI	Essa Pharma Inc
07/15/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...	TSXV:EPI	Essa Pharma Inc
06/22/2020	6:30AM	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...	TSXV:EPI	Essa Pharma Inc
05/27/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference	TSXV:EPI	Essa Pharma Inc
05/15/2020	6:30AM	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting	TSXV:EPI	Essa Pharma Inc
05/07/2020	4:05PM	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020	TSXV:EPI	Essa Pharma Inc
04/30/2020	4:45PM	PR Newswire (Canada)	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer	TSXV:EPI	Essa Pharma Inc
04/13/2020	5:08PM	PR Newswire (Canada)	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	TSXV:EPI	Essa Pharma Inc
03/31/2020	6:00AM	PR Newswire (Canada)	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update	TSXV:EPI	Essa Pharma Inc
02/27/2020	6:51PM	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
02/13/2020	4:48PM	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019	TSXV:EPI	Essa Pharma Inc
02/10/2020	5:15PM	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc

Showing the most relevant articles for your search:TSXV:EPI

1 2 3 4 Next >>

Impact Fusion (PK)

Trump Media and Technology

Voip Pal Com (QB)

Lightwave Logic

Anavex Life Sciences

Net Savings Link (PK)

TPT Global Tech (PK)

Rennova Health (PK)

AMC Entertainment

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions